Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities.
Ontology highlight
ABSTRACT: Nanoparticle (NP) imaging applications have the potential to improve cancer diagnostics, therapeutics, and treatment management. In biomedical research and clinical practice, NPs can serve as labels or labeled carriers for monitoring drug delivery or serve as imaging agents for enhanced imaging contrast, as well as providing improved signal sensitivity and specificity for in vivo imaging of molecular and cellular processes. These qualities offer exciting opportunities for NP-based imaging agents to address current limitations in oncologic imaging. Despite substantial advancements in NP design and development, very few NP-based imaging agents have translated into clinics within the past 5 years. This review highlights some promising NP-enabled imaging techniques and their potential to addre
SUBMITTER: Liu CH
PROVIDER: S-EPMC8183257 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
ACCESS DATA